U.S. regulators have expanded the use of pharmaceutical company Merck’s cervical cancer vaccine to adults up to age 45, according to a new report from The Associated Press.
Get the top stories of the day around the DMV.
U.S. regulators have expanded the use of pharmaceutical company Merck’s cervical cancer vaccine to adults up to age 45, according to a new report from The Associated Press.